Paolo Martelletti
#151,639
Most Influential Person Now
Researcher
Paolo Martelletti's AcademicInfluence.com Rankings
Paolo Martellettiphilosophy Degrees
Philosophy
#8400
World Rank
#11778
Historical Rank
Logic
#5439
World Rank
#6840
Historical Rank
Download Badge
Philosophy
Why Is Paolo Martelletti Influential?
(Suggest an Edit or Addition)Paolo Martelletti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (2019) (250)
- Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) (2012) (249)
- Neuromodulation of chronic headaches: position statement from the European Headache Federation (2013) (216)
- Headache disorders are third cause of disability worldwide (2015) (193)
- Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor (2020) (190)
- Noninvasive vagus nerve stimulation as acute therapy for migraine (2018) (165)
- A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience (2016) (146)
- Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk (2009) (143)
- Aids to management of headache disorders in primary care (2nd edition) (2019) (134)
- Gut-brain Axis and migraine headache: a comprehensive review (2020) (124)
- Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017) (118)
- My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) (108)
- Current and emerging evidence-based treatment options in chronic migraine: a narrative review (2019) (102)
- Underdiagnosis and Undertreatment of Migraine in Italy: A Survey of Patients Attending for The First Time 10 Headache Centres (2009) (97)
- Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation (2014) (94)
- European headache federation consensus on technical investigation for primary headache disorders (2015) (92)
- Diagnosis and management of migraine in ten steps (2021) (92)
- European headache federation consensus on the definition of resistant and refractory migraine (2020) (91)
- Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation (2014) (91)
- European principles of management of common headache disorders in primary care. (2007) (91)
- Gepants for the treatment of migraine (2019) (90)
- Chronic migraine plus medication overuse headache: two entities or not? (2011) (90)
- ‘Ictal epileptic headache’: Recent concepts for new classifications criteria (2012) (89)
- Psychiatric comorbidity and suicide risk in patients with chronic migraine (2010) (85)
- A six year retrospective review of occipital nerve stimulation practice - controversies and challenges of an emerging technique for treating refractory headache syndromes (2013) (85)
- Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation (2018) (81)
- The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action (2011) (80)
- Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains (2017) (76)
- Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. (2012) (75)
- Lifting The Burden: the first 7 years (2010) (70)
- CGRP receptor antagonists: an expanding drug class for acute migraine? (2012) (70)
- Emerging treatment for chronic migraine and refractory chronic migraine (2012) (69)
- Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients (1997) (69)
- Impact of migraine on fibromyalgia symptoms (2016) (68)
- Association of diet and headache (2019) (66)
- Altered kynurenine pathway metabolites in serum of chronic migraine patients (2016) (65)
- CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? (2019) (65)
- Tumor Necrosis Factor Gene Polymorphism in Migraine (2002) (65)
- OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study (2015) (63)
- Genetics of migraine and pharmacogenomics: some considerations (2007) (63)
- Migraine and sleep disorders: a systematic review (2020) (61)
- Improving care through health economics analyses: cost of illness and headache (2008) (58)
- A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine (2011) (58)
- Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection (2020) (57)
- Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine (2006) (54)
- New IgM seroconversion and positive RT‐PCR test after exposure to the virus in recovered COVID‐19 patient (2020) (54)
- Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential (2018) (54)
- Ictal epileptic headache: an old story with courses and appeals (2012) (53)
- New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? (2013) (52)
- Aids for management of common headache disorders in primary care (2007) (52)
- Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open‐label, exploratory study (2016) (51)
- An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study (2019) (50)
- Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH) (2018) (49)
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update (2022) (49)
- Low Plasma Testosterone Levels in Cluster Headache* (1983) (48)
- The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders (2013) (46)
- Altered serum levels of kynurenine metabolites in patients affected by cluster headache (2016) (46)
- Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience (2006) (46)
- Chronic migraine: comorbidities, risk factors, and rehabilitation (2010) (45)
- Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study (2021) (45)
- The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE) (2005) (45)
- Serum Interleukin-1 Beta is Increased in Cluster Headache (1993) (44)
- Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives (2020) (43)
- Linked Activation of Nitric Oxide Synthase and Cyclooxygenase in Peripheral Monocytes of Asymptomatic Migraine Without Aura Patients (2000) (42)
- Optimising migraine treatment: from drug-drug interactions to personalized medicine (2019) (41)
- Anti-CGRP monoclonal antibodies in migraine: current perspectives (2016) (40)
- Long-COVID Headache (2021) (40)
- Comorbidities of primary headache disorders: a literature review with meta-analysis (2021) (40)
- Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients (2020) (39)
- Chronic migraine: current concepts and ongoing treatments. (2011) (39)
- Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre (2019) (39)
- Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine (2010) (39)
- Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (2017) (38)
- Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review (2020) (38)
- Emerging drugs for migraine treatment: an update (2018) (38)
- Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab (2017) (36)
- Emerging drugs for migraine treatment (2015) (35)
- COVID-19: is it just a lung disease? A case-based review (2020) (34)
- Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study (2007) (34)
- The role of physical activity in the prevention and treatment of chronic diseases. (2010) (34)
- Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache (2008) (34)
- Correlation between Migraine Severity and Cholesterol Levels (2015) (33)
- Lasmiditan for the treatment of migraine (2017) (33)
- Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia (2008) (33)
- Cervicogenic Headache (2004) (32)
- Time to act on headache disorders (2011) (32)
- Acute headache management in emergency department. A narrative review (2020) (32)
- Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine (2010) (31)
- Proinflammatory pathways in cervicogenic headache. (2000) (31)
- Chromosome 6p-encoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. (1999) (31)
- Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations (2016) (31)
- Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence (2020) (30)
- Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study (2012) (30)
- Structural and Functional Brain Changes in Migraine (2021) (30)
- Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial (2018) (29)
- Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial (2018) (29)
- Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) (2021) (29)
- Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers (2017) (28)
- HLA‐B14 Antigen in Cluster Headache (1984) (28)
- The therapeutic armamentarium in migraine is quite elderly (2015) (28)
- Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations (2013) (27)
- Putative Neuroimmunological Mechanisms in Cluster Headache. An Integrated Hypothesis (1996) (26)
- Variations in the Leu7+ and LeuM3+ Leukocyte Subpopulations Observed in Cluster Headache are Dependent on HLA‐DR Antigens (1987) (26)
- Epidural corticosteroid blockade in cervicogenic headache. (1998) (26)
- Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways. (1997) (25)
- The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard (2007) (25)
- Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life (2018) (25)
- Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response (2016) (25)
- Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report (2020) (24)
- Chronic migraine treatment: from OnabotulinumtoxinA onwards (2016) (24)
- The omics in migraine (2013) (24)
- Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice (2012) (24)
- Extremely Severe Case of COVID-19 Pneumonia Recovered Despite Bad Prognostic Indicators: a Didactic Report (2020) (24)
- Use of Nonsteroidal Anti‐Inflammatory Drugs for Symptomatic Treatment of Episodic Headache (2017) (24)
- Aspirin and tension-type headache (2007) (24)
- Modulation of nitric oxide synthase by nitric oxide donor compounds in migraine (1998) (23)
- Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important (2015) (23)
- “Capsaicin‐Sensitive” Sensory Neurons in Cluster Headache: Pathophysiological Aspects and Therapeutic Indication (1994) (23)
- Patient outcome in migraine prophylaxis: the role of psychopharmacological agents (2010) (22)
- Global Burden of Headache Disorders in Children and Adolescents 2007–2017 (2020) (22)
- Proinflammatory cytokines in cervicogenic headache. (1999) (22)
- Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy (2011) (22)
- The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and Priorities (2017) (22)
- Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies (2019) (22)
- Headache service quality: evaluation of quality indicators in 14 specialist-care centres (2016) (22)
- Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs) (2019) (22)
- Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance (2021) (22)
- Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance (2021) (22)
- Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial (2018) (21)
- Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial (2018) (21)
- Persistent Post-Traumatic Headache and Migraine: Pre-Clinical Comparisons (2020) (21)
- Pharmacokinetic evaluation of frovatriptan (2011) (21)
- The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine (2018) (20)
- Sodium channel antagonists for the treatment of migraine (2014) (20)
- The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers (2008) (20)
- Advances in orally administered pharmacotherapy for the treatment of migraine (2018) (20)
- Rapid referral for headache management from emergency department to headache centre: four years data (2020) (20)
- Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research (2020) (20)
- Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? (2020) (20)
- Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data (2017) (19)
- Handbook of Headache (2011) (19)
- Treatment of Perimenstrual Migraine with Triptans: an Update (2012) (19)
- Elevated Frequency of HLA Shared‐Haplotypes in Migraine Families (1987) (19)
- Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches (2021) (19)
- Pharmacogenomics in migraine: catching biomarkers for a predictable disease control (2009) (19)
- Disruption of the Immunopeptidergic Network in Dietary Migraine (1993) (19)
- Reduced Activity of the NK Cells from Patients with Cluster Headache and the “In Vitro” Response to β‐Interferon (1987) (18)
- Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines (2012) (18)
- Defect of Serotonin Binding to Mononuclear Cells from Episodic Cluster Headache Patients (1987) (18)
- Fremanezumab for the preventive treatment of migraine in adults (2019) (17)
- Medication overuse and drug addiction: a narrative review from addiction perspective (2021) (17)
- Ubrogepant for the treatment of migraine (2020) (17)
- Enzymatic and metabolic changes in peripheral serum after superior mesenteric artery ligation in dogs. (1983) (17)
- A Critical Evaluation on MOH Current Treatments (2017) (17)
- Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis (2022) (17)
- Greater occipital nerve as target for refractory chronic headaches: from corticosteroid block to invasive neurostimulation and back (2016) (17)
- Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence (2020) (16)
- Evidence for an Immune‐Mediated Mechanism in Food‐Induced Migraine from a Study on Activated T‐Cells, IgG 4 Subclass, Anti‐lgG Antibodies and Circulating Immune Complexes (1989) (16)
- Pharmacogenetic considerations for migraine therapies (2018) (16)
- Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention (2019) (16)
- Psychometric properties of the stagnation scale in medication overuse headache patients (2015) (16)
- Position Paper on Post-Traumatic Headache: The Relationship Between Head Trauma, Stress Disorder, and Migraine (2020) (16)
- Overattachment and perceived disability in chronic migraineurs (2013) (16)
- White matter hyperintensities and self-reported depression in a sample of patients with chronic headache (2012) (15)
- Case-control study on the epidemiology of cluster headache. II: Anthropometric data and personality profile. (2000) (15)
- Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic class (2008) (15)
- Deprescribing in migraine (2021) (15)
- Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate (2020) (15)
- Access to COVID-19 Vaccination during the Pandemic in the Informal Settlements of Rome (2022) (14)
- Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation (2018) (14)
- Cluster headache management and beyond (2015) (14)
- Profiling lasmiditan as a treatment option for migraine (2019) (14)
- Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? (2011) (14)
- Impairment of 5HT Binding to Lymphocytes and Monocytes From Tension‐Type Headache Patients (1990) (14)
- CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine (2021) (14)
- Update on Medication-Overuse Headache and Its Treatment (2015) (14)
- Acute migraine in the Emergency Department: extending European principles of management (2008) (13)
- Migraine and cluster headache show impaired neurosteroids patterns (2019) (13)
- What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group (2020) (13)
- The Relation between Persistent Post-Traumatic Headache and PTSD: Similarities and Possible Differences (2020) (13)
- Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity (2014) (13)
- Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability (2020) (13)
- Headache: Cluster headache treatment — RCTs versus real-world evidence (2016) (13)
- Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment (2021) (13)
- Academic specialist education in headache medicine. Next move for the headache community (2005) (13)
- Pharmacogenetic insights into migraine treatment in children. (2014) (13)
- The unfinished war (2002) (13)
- How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms? (2021) (13)
- Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches (2014) (13)
- Basophil Histamine Release and Leukotriene (LTB4 ‐ LTC4) Production in Cluster Headache (1989) (12)
- Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial (2019) (12)
- Atogepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine (2020) (12)
- Fremanezumab for the prevention of chronic and episodic migraine. (2019) (12)
- Première of a partnership: European Headache Federation and The Journal of Headache and Pain (2006) (12)
- Combination therapy in migraine: asset or issue? (2020) (12)
- Cluster headache: a quasi-rare disorder needing a reappraisal (2015) (12)
- Thrombosis of the retinal artery in a patient with Churg-Strauss syndrome. (2001) (12)
- Handbook of headache : practical management (2011) (11)
- Evaluating and managing severe headache in the emergency department (2020) (11)
- In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attack (1988) (11)
- Novel synthetic treatment options for migraine (2020) (11)
- Long COVID headache (2022) (11)
- Erenumab is effective in reducing migraine frequency and improving physical functioning (2018) (11)
- Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization (2020) (11)
- Starting Tutorials in headache medicine education (2006) (10)
- Depression and insomnia are independently associated with satisfaction and enjoyment of life in medication-overuse headache patients (2016) (10)
- Headache and mood disorders (2005) (10)
- Epidural steroid-based technique for cervicogenic headache diagnosis. (1998) (10)
- Chronopathology for angiotensin converting enzyme circadian rhythm in migraine. (1990) (10)
- Enhancement of Circulating Immune Complexes in Episodic Cluster Headache: Interaction with Lymphocyte and Monocyte Subsets (1986) (10)
- How do you choose the appropriate migraine pharmacotherapy for an elderly person? (2018) (10)
- Migraine with aura, bipolar depression, ACM aneurysm. A case report (2005) (10)
- Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy (2020) (10)
- Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine (2018) (10)
- The therapeutic potential of novel anti-migraine acute therapies (2015) (10)
- Role of NSAIDs in acute treatment of headache (2007) (10)
- Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study (2021) (10)
- Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre (2020) (10)
- Inflammatory mechanisms in cervicogenic headache: An integrative view (2002) (10)
- Efficacy and tolerability of almotriptan in menstrual migraine: a comment (2011) (9)
- The Global Campaign turns 18: a brief review of its activities and achievements (2022) (9)
- Positioning the new drugs for migraine (2022) (9)
- Future drugs for migraine (2009) (9)
- Cluster Headache and other Trigeminal Autonomic Cephalgias (2020) (9)
- The clinical and public health implications and risks of widening the definition of chronic migraine (2019) (9)
- Job Satisfaction Mediates the Association between Perceived Disability and Work Productivity in Migraine Headache Patients (2019) (9)
- Nitric oxide: emerging implications for headache mechanics (2001) (9)
- Reduction in expenditures on analgesics during one year of treatment of chronic tension headache with BoNT-A (2003) (9)
- Expression of NOS–2, COX–2 and Th1/Th2 cytokines in migraine (2001) (8)
- European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure (2022) (8)
- Treatment of menstrual migraine: utility of control of related mood disturbances (2014) (8)
- Acute treatment of migraine: quo vadis? (2017) (8)
- Chronic daily headache and medication overuse headache: clinical read-outs and rehabilitation procedures. (2007) (8)
- Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population (2015) (8)
- Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey (2021) (8)
- Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation (2014) (8)
- Migraine disability complicated by medication overuse (2018) (8)
- Tumor necrosis factor B gene polymorphism contributes to susceptibility to migraine without area (2000) (8)
- The global impact of migraine (2003) (7)
- Rimegepant for the treatment of migraine. (2020) (7)
- Measure of negative impact of migraine on daily activities, social relationships and therapeutic approach (2004) (7)
- A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache (2004) (7)
- Headache Medicine: Academic Teaching in Europe. The Sapienza University Master's Degree (2007) (7)
- Neuromodulation in Headache and Facial Pain Management: Principles, Rationale and Clinical Data (2020) (7)
- Dispute settlement understanding on the use of BOTOX® in chronic migraine (2011) (7)
- Deciphering the task of N-acetyl aspartate in migraine (2012) (6)
- Stigma and Chronic Pain (2022) (6)
- Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis (2022) (6)
- Unmet needs for migraine (2021) (6)
- Pharmacokinetic evaluation of almotriptan for the treatment of migraines (2013) (6)
- TNFA gene: the -308 promoter polymorphism in migraine (2000) (6)
- Failure of long-term results of epidural steroid injection in cervicogenic headache. (1998) (6)
- Immunological phenomena in cluster headache: a controversy. (1987) (6)
- Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine (2022) (6)
- The Role of Adhesion Molecules in Migraine: A Debate (2000) (6)
- Connection Between Lower Natural Killer Function And Susceptibility To Viral Infection In Cluster Headache (1987) (6)
- Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study (2021) (6)
- T cells expressing IL-2 receptor in migraine. (1991) (6)
- Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine (2019) (6)
- Zavegepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Treatment of migraine (2021) (6)
- Pharmacogenomics in migraine: Catching biomarkers for a predictable disease control (Expert Review of Neurotherapeutics (2009) 9, (9), (1267-1269)) (2009) (6)
- Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan. (1994) (6)
- Eptinezumab for the treatment of migraine (2021) (6)
- Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready (2013) (5)
- Analgesic therapy for headache: consumption, appropriateness and costs (2003) (5)
- Societal Impact of Headache: Burden, Costs and Response (2019) (5)
- Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms (2020) (5)
- The future of pharmacogenetics in the treatment of migraine. (2019) (5)
- Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients (2021) (5)
- Migraine: a food-related immune reaction? (1989) (5)
- Histamine skin test in cluster headache: effects of dihydroergotamine with timed release (1983) (5)
- Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? (2018) (5)
- Genetic markers of cluster headache and the links with the lithium salts therapy. (1986) (5)
- Bioelectrical Impedance Assay (BIA) of Total Body Composition in Alcohol‐Induced Migraine Patients. Preliminary Report. (1991) (5)
- P003. NSAIDs for symptomatic treatment of headache (2015) (5)
- An unexpected and suspended time (2020) (5)
- Hormonal therapies in migraine management: current perspectives on patient selection and risk management (2021) (5)
- The Journal of Headache and Pain keeps gaining consensus (2010) (5)
- Impairment of cytolytic and proliferative responsiveness of peripheral blood mononuclear cells from cluster headache patients to IL-2. (1992) (5)
- Function of the Peripheral Serotoninergic Pathways in Migraine: A Proposal for An Experimental Model (1994) (5)
- Rimegepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Treatment of migraine (2019) (5)
- Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors (2022) (5)
- Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes (2022) (4)
- P064. 12 years of Master Degree in Headache Medicine at Sapienza University of Rome (2015) (4)
- P070. A 2-year prospective evaluation study on onabotulinumtoxinA 155 U in chronic migraine (2015) (4)
- Cytotoxic T lymphocyte antigen 4 polymorphism 49 (A→G) and migraine (2005) (4)
- Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2018) (4)
- Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators (2018) (4)
- OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study (2022) (4)
- ["Chronic paroxysmal hemicrania" following ophthalmic herpes zoster]. (1992) (4)
- O068. A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine (2015) (4)
- Acute, transitional and long-term cluster headache treatment: pharmacokinetic issues (2016) (4)
- Gender and Migraine (2019) (4)
- Neurophysiology of the Migraine Brain (2021) (4)
- A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache (2004) (4)
- Etiology of ‘Sinus Headache’—Moving the Focus from Rhinology to Neurology. A Systematic Review (2021) (3)
- Cutaneous Responsiveness to Histamine in Cluster Headache (1985) (3)
- Comorbidities in Headache Disorders (2017) (3)
- [Alexithymic features and emotional distress in patients with chronic tension-type headache (CTTH) and medication-overuse headache (MOH)]. (2008) (3)
- [Chronic daily headache: management and rehabilitation]. (2006) (3)
- A Study on Headache Disorder in Kingdom Of Saudi Arabia Review (October 2013) (2016) (3)
- Cluster Headache is Still Lurking in the Shadows (2021) (3)
- Is the unresponsiveness to sumatriptan in cluster headache related to an alteration in the 5-HT receptors? (1993) (3)
- Monocyte population increase in cluster headache a new immunological aspect (1985) (3)
- Real-Life Use of OnabotulinumtoxinA for the Symptomatic Treatment of Chronic Migraine: The REPOSE Study (P4.150) (2018) (3)
- Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach (2018) (3)
- Neuroendocrine Derangement in Chronic Migraine (2006) (3)
- Price differentials of oral triptans in eight European Union countries (2003) (3)
- NK-Mediated Links for Migraine (1998) (3)
- Tackling the perils of unawareness: the cluster headache case (2017) (3)
- Health status after detoxification in medication overuse headache (2004) (3)
- While climbing the hill, you think it’s possible (2009) (2)
- On the web (2001) (2)
- [New contributions on extinction tests of essential headache. II. The test with indoprofen]. (1983) (2)
- The road ahead for chronic headache patients (2006) (2)
- Headache Induced by Accidental Nitric Acid Inhalation (2004) (2)
- Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN (2021) (2)
- Preventive treatment of headache with slow-release dihydroergotamine : comparison of dosage protocols (1991) (2)
- The Migraine Stigma Kaleidoscope View. (2023) (2)
- New Model for Non-Invasive Echocardiographic Assessment of Pulmonary-Capillary Wedge Pressure in Patients With Aortic and Mitral Regurgitation (2020) (2)
- Narrative-based medicine in headache disorders (2022) (2)
- Acute Tuberculosis pneumonia and COVID-19 in a patient vaccinated with Bacille Calmette-Guérin (BCG) (2020) (2)
- P067. Multimodal therapy in the management of MOH: a 3-year experience (2015) (2)
- [Immunologic approach in cluster headache]. (1987) (2)
- Computerized Telethermographic Assessment in Migraine, with Particular Reference to the Prodromal Phase (1986) (2)
- Impaired natural killer activity in PBLs from cluster headache patients is restored by interleukin 2 (1990) (2)
- A tasty cultural event (2012) (2)
- Migraine Outcome Should Not Be Used to Determine Diagnosis, Severity, and Therapy: Moving Towards a Multiparametric Definition of Chronicity (2022) (2)
- Non Drug Treatment for Migraine Headache With Associated Raynaud's Disease (1985) (2)
- Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial (2018) (2)
- Headache and emergency medicine: sharing a language for a common project (2008) (2)
- O065. Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report (2015) (2)
- Randomized Controlled Study of Non-invasive Vagus Nerve Stimulation (nVNS) for the Acute Treatment of Migraine: The PRESTO Trial (S43.005) (2018) (2)
- An unaddicted impact factor (2013) (2)
- Recently approved and emerging drug options for migraine prophylaxis (2022) (2)
- Raised Titers Of Antibodies To Herpes And Epstein-Barr Viruses In Cluster Headache Detected By Emjnofluorescence (1987) (2)
- New policies to consolidate the journal’s hold on its latest position (2008) (2)
- Approaching the appropriate pharmacotherapy of menstrual migraine (2019) (2)
- Correction to: Medication overuse and drug addiction: a narrative review from addiction perspective (2021) (2)
- Peripheral Interventional Management in Headache (2019) (2)
- Insights into headache 2022 (2022) (2)
- Monocytes Leum3+ and Cluster Headache: Preliminary Report (1985) (2)
- A tier-upon-tier march towards the impact factor (2008) (2)
- Questioning on consistency of a Stagnation Scale in Medication Overuse Headache: one more added to a plea of emperor’s clothes? (2015) (2)
- Unmet Needs in Preventive Treatment of Migraine (2023) (2)
- The evaluation of the intracavitary effusions by a beside ultrasound examination. (2022) (2)
- Treatment of Cluster Headache and Other Trigeminal Autonomic Cephalalgias (2011) (1)
- Immune Response Time-Course after Challenge Test in Food-Induced Migraine (1989) (1)
- What to Tell Patients About Migraine (2011) (1)
- Thoughts on the past year of Journal of Headache and Pain (2008) (1)
- Efficiency of occlusal splint therapy on orofacial muscle pain reduction: a systematic review (2023) (1)
- Assessment of the antiserotoninergic effect of naftidrofuril by means of a study of receptor binding of serotonin to mononuclear cells in patients suffering from migraine (1991) (1)
- Editor–in–Chief’s 2006 Report (2006) (1)
- Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties (2003) (1)
- Activity of Cromolyn Sodium in Dietary Migraine: A Double-Blend Placebo-Controlled Multicenter Trial (1991) (1)
- HLA and migraine genes (2000) (1)
- What to Tell Patients About Cluster Headache (2011) (1)
- Drug-Induced Brugada Syndrome in a Psychiatric Patient: a Case Report (2019) (1)
- A Pilot Study on the Association of Lead, 8-Hydroxyguanine, and Malondialdehyde Levels in Opium Addicts’ Blood Serum with Illicit Drug Use and Non-Addict Persons (2022) (1)
- Telethermographic Investigations in Migraine Patients before and after Flunarizine Treatment (1985) (1)
- [Cluster headache appearing after Ramsey Hunt syndrome and antigens of the HLA system. Description of a case]. (1987) (1)
- Altered Circadian Rhythmicity for Angiotensin Converting Enzyme Activity in Migraine (1988) (1)
- Stimulated expression of IL-2 receptors on lymphocytes and enhanced IL-2 plasma levels after challenge test in food-induced migraine (1991) (1)
- CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury (2021) (1)
- Erratum to: 1st Joint ANIRCEF-SISC Congress (meeting abstracts) (2017) (1)
- Churg-Strauss syndrome or other disease? Authors' reply (2002) (1)
- Polyamines serum levels in episodic and chronic migraine (2020) (1)
- Placebos and Nocebos in Headaches (2019) (1)
- Unmet Needs in Headache Management (2019) (1)
- Framing comorbidities and co-occurrences in a migraine with aura patient (2014) (1)
- Il-2 Induces Pha Proliferation in Peripheral Blood Mononuclear Cells from Cluster Headache Patients (1991) (1)
- [Aspects of organ-specific autoimmunity in cluster headache]. (1989) (1)
- Medical Interventions for Migraine That Has Become Difficult to Treat (2011) (1)
- [Cluster headache, Epstein-Barr and Burkitt's lymphoma virus infections]. (1989) (1)
- [The cluster headache: a clinical model of immunologic receptor pathology?]. (1992) (1)
- Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations (2015) (1)
- Chronicling the June conundrum (2011) (1)
- Headache disorders: Building specialist education (2010) (1)
- Elevated Frequency Of Hla Shared-Aplotypes In Migraine Families (1987) (1)
- The genetic regulation of SCN in cluster headache may be affected by Th1/Th2 cytokine derangement (2000) (1)
- Defining Criteria of a Putative Inflammatory Headache Syndrome: Cluster Headache (2001) (1)
- Cognition, disability and quality of life of patients with chronic migraine (2017) (1)
- What to Tell Patients About Tension-Type Headache (2011) (1)
- 265 Incidence, determinants and prognostic relevance of HS-troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients (2020) (1)
- O066. Kynurenine pathway metabolites in cluster headache (2015) (1)
- The changing faces of migraine (2019) (1)
- [Personality profiles in headache patients, non-responders to drug therapy]. (1987) (1)
- Dismantling the Barriers (2019) (1)
- Progressive Deactivation of 5HT Receptors on Mononuclear Cells during Migraine Crisis (1989) (1)
- Efficacy of frovatriptan versus almotriptan for acute treatmentof menstrual migraine: analysis of a double-blind, randomized,crossover, multicentre Italian, comparative study (2012) (1)
- NK-mediated links for migraine. (1998) (1)
- EHMTI-0322. Effect of cervical epidural 10khz spinal cord stimulation on patients suffering from chronic, medically-refractory migraine (2014) (1)
- Prophylaxis of Food-Induced Migraine with Cromolyn Sodium: Efficacy of Short- and Long-Term Use (1989) (1)
- What to Tell Patients About Headache Occurring on More Days Than Not (2011) (1)
- [Verification of the validity of the Giacovazzo skin test with histamine at neutral pH]. (1984) (0)
- Reduced IL-2 Receptor Expression on Peripheral Blood Lymphocytes from Cluster Headache Patients (1989) (0)
- [Hydrops articulorum intermittens with premenstrual occurrence: physiopathologic and therapeutic considerations]. (1978) (0)
- OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity (2022) (0)
- Hesitancies in primary headaches treatments (2022) (0)
- STRESS HORMONES IN CHRONIC MIGRAINE ARE MODULATED BY BOTULINUM TOXIN -TYPE A (2006) (0)
- Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients? (2022) (0)
- [Genetic and immunoneuromodulatory aspects in hemicrania]. (1988) (0)
- [The puerperium and dysnociception. II) Behavior of serum serotonin in pregnant and post-partum animals]. (1981) (0)
- A bedside ultrasound protocol to the measurement of the systemic vascular resistances: Preliminary results in the patients with sepsis. (2022) (0)
- [The puerperium and dysnociception. I) Behavior of serum beta-endorphins in pregnant and post-partum animals]. (1981) (0)
- Reaching the Nadir of Medication Overuse in Chronic Migraine (2022) (0)
- Cytomegalovirus Reactivation in Critically Ill Patient: Cause or Consequence? A Case Report and Literature Review (2019) (0)
- Prophylactic Drugs (2019) (0)
- Price differentials and utilizations of selective 5-HT1-receptor agonists in the European Countries (2003) (0)
- New Migraine Drugs for Older Adults (2023) (0)
- Refractory Chronic Migraine: Therapy with Combined Peripheral Neurostimulation (2015) (0)
- The changing comet (2017) (0)
- Chronic Migraine Complicated by Medication Overuse Headache (2015) (0)
- Changes in Total Body Water Measured by Bioelectrical Impedance in Alcohol-Induced Migraine (1991) (0)
- Thirtieth Annual Meeting The American Association for the Study of Headache June 18‐19, 1988, San Francisco, California (1988) (0)
- Right Heart Thrombus and Pulmonary Embolism in Patients with Life-Threatening Bleeding: Management of a Complex Condition (2021) (0)
- 209 Increased burden of headache in patients with migraine complicated by MOH: sub-group analysis BECOME study (2022) (0)
- HERALDING A NEW ERA OF EPISODIC, CHRONIC AND REFRACTORY MIGRAINE MANAGEMENT INDEPENDENT MEDICAL EDUCATION SYMPOSIUM SCIENTIFIC SUMMARY HERALDING A NEW ERA OF EPISODIC, CHRONIC AND REFRACTORY MIGRAINE MANAGEMENT (2018) (0)
- Treatment and Prevention of Migraine (2011) (0)
- Long COVID and especially headache syndromes (2023) (0)
- Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum] (2018) (0)
- Flail Mitral Valve Associated with Iliac Artery Aneurysm: Diagnostic Challenges of a Potential Syndromic Pattern. Case Report (2020) (0)
- Mediterranean Symposium of rheumatology (1985) (0)
- Overview of Common and Important Headache Disorders (2011) (0)
- [The puerperium and dysnociception. III) Serotonin and beta-endorphin levels in pregnant rats fed L-tryptophan]. (1981) (0)
- Acquired Haemophilia in A Old Patient with Non Small Lung Cancer: A Case Report. (2022) (0)
- Comprar Handbook of Headache | Martelletti, Paolo | 9788847017009 | Springer (2011) (0)
- The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer’s disease (2021) (0)
- Comprar Comorbidities In Headache Disorders (Headache) | Maria Adele Giamberardino | 9783319414522 | Springer (2016) (0)
- Related articles (2014) (0)
- General Principles of Pharmacotherapy for Headache Disorders (2016) (0)
- [Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine]. (1978) (0)
- Thoughts on the past year of Journal of Headache and Pain (2008) (0)
- Frovatriptan vs almotriptan for treatment of menstrual migraine: a double-blind, randomized, cross-over, multicenter Italian study (2013) (0)
- A Case Report of Schistosomiasis in Eritrean Man: from Hypothesis to Diagnosis (2018) (0)
- Thiamine Deficiency in the Pathophysiology and Diagnosis of Wernicke-Korsakoff Syndrome: Case Report and Literature Review (2022) (0)
- Stimulation of Lymphocyte Natural Cytotoxicity Tn Cluster Headache Patients by Melatonin Treatment (1991) (0)
- Pharmacovigilance on drugs for headache and pain (2002) (0)
- Migraine Versus Cluster Headache and Potential Other Indications (2021) (0)
- Two decades, a new editorial stylistic feature (2020) (0)
- One Health for Headaches: A Clinical Scientist Residence Project (2023) (0)
- The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and Priorities (2017) (0)
- The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer's disease. (2020) (0)
- Invasive neurostimulation (2015) (0)
- How to measure headache service quality : evaluation of quality indicators in 14 European specialist-care centres (2016) (0)
- Service quality in headache care: A study in 14 specialized centres in Europe (2016) (0)
- [Blood calcium in experimental headache]. (1985) (0)
- Headache and psychiatry (2020) (0)
- Abstracts of the 8th Headache Congress of the European Headache Federation, Valencia, Spain, 26-29 April 2006. (2006) (0)
- [New contributions on extinction tests of essential headache. III. The test with tiapride]. (1983) (0)
- Journal Citation Reports® 2013 tells headache experts that competitive environment has changed (2014) (0)
- Greppi-Sicuteri Committee: Giorgio (2006) (0)
- The baton changed hands (2021) (0)
- EV435Life satisfaction and enjoyment in medication-overuse headache patients: The role of depression and insomnia (2016) (0)
- COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache (2023) (0)
- Gleaning after the European Headache Federation consensus statement on refractory chronic migraine (2014) (0)
- Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial (2023) (0)
- Mapping headache disorders' impact assessments measures against the biopsychosocial model of health and disability of the ICF classification (2021) (0)
- [Analysis of the clinical experience with 136 patients with headache treated with lisuride]. (1984) (0)
- Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (2018) (0)
- [New contributions on extinction tests of essential headache. I. The test with lysine acetylsalicylate]. (1983) (0)
- 115 Economic burden among migraine patients: United Kingdom perspective (2019) (0)
- Novel migraine therapeutic target discovery by single-cell RNA sequencing of trigeminal ganglia (2017) (0)
- “Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies (2020) (0)
- Practical Insights on the Identification and Management of Patients with Chronic Migraine (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Martelletti?
Paolo Martelletti is affiliated with the following schools:
